Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results (Showing 1 to 6 of 6)As of 10-Feb-2010
New Screen 

All Reports | Brokerage Reports | Independent Reports
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
4-Feb-10Caris & CompanyJames MolloyAUXL (Caris Update)-FDA Approves Xiaflex, Good Label7$25  View Abstract
2-Feb-10Caris & CompanyJames MolloyWCRX - Buy WCRX for 2011-2012 EPS Leverage9$25  View Abstract
25-Jan-10Caris & CompanyJames MolloyWCRX - Positive Guidance Number Priced In8$25  View Abstract
19-Jan-10Caris & CompanyJames MolloyENDP-Lowering PT to $25 to Account for Lidoderm Threat8$25  View Abstract
19-Jan-10Caris & CompanyJames MolloyDEPO-News Flash: FDA Agrees with DEPO!9$25  View Abstract
29-Dec-09Caris & CompanyJames MolloyPharmaceuticals - Specialty Pharma Picks for 201016$50  View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.